LncRNAs in adaptive immunity: role in physiological and pathological conditions

References

• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016 Jan;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for the ENCODE project. Genome Res. 2012;22(9):1760–1774.
   PubMed Web of Science ®Google Scholar
• Chan WL, Chang YS, Yang WK, et al. Very long non-coding RNA and human disease. Biomed. 2012;2(4):167–173.
   Google Scholar
• Fang S, Zhang L, Guo J, et al. NONCODEV5: a comprehensive annotation database for long non-coding RNAs. Nucleic Acids Res. 2018;46(D1):D308–D314.
   PubMed Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011 Sep 15;25(18):1915–1927.
   Google Scholar
• Sun M, Kraus WL. From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev. 2015;36(1):25–64.
   PubMed Web of Science ®Google Scholar
• Perry RBT, Hezroni H, Goldrich MJ, et al. Regulation of neuroregeneration by long noncoding RNAs. Mol Cell. 2018;72(3):553–567.e5.
   PubMed Web of Science ®Google Scholar
• Zhang ZK, Li J, Guan D, et al. Long noncoding RNA lncMUMA reverses established skeletal muscle atrophy following mechanical unloading. Mol Ther. 2018;26(11):2669–2680.
   PubMed Web of Science ®Google Scholar
• Ivaldi MS, Diaz LF, Chakalova L, et al. Fetal g-globin genes are regulated by the BGLT3 long noncoding RNA locus. Blood. 2018;132(18):1963–1973.
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21.
   PubMed Web of Science ®Google Scholar
• Nagano T, Fraser P. Emerging similarities in epigenetic gene silencing by long noncoding RNAs. Mamm Genome. 2009;20(9–10):557–562.
   PubMed Web of Science ®Google Scholar
• Stojic L, Lun ATL, Mascalchi P, et al. A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell division. Nat Commun. 2020;11(1).
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914.
   PubMed Web of Science ®Google Scholar
• Hu G, Tang Q, Sharma S, et al. Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol. 2013;14(11):1190–1198.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352.
   PubMed Web of Science ®Google Scholar
• Guo C-J, Ma XK, Xing YH, et al. Distinct processing of lncRNAs contributes to non-conserved functions in stem cells. Cell. 2020;1–16.
   Web of Science ®Google Scholar
• Yoon JH, Abdelmohsen K, Srikantan S, et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell. 2012;47(4):648–655.
   PubMed Web of Science ®Google Scholar
• Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19(3):143–157.
   PubMed Web of Science ®Google Scholar
• Signal B, Gloss BS, Dinger ME. Computational approaches for functional prediction and characterisation of long noncoding RNAs. Trends Genet. 2016;32(10):620–637.
   PubMed Web of Science ®Google Scholar
• de Santa F, Barozzi I, Mietton F, et al. A large fraction of extragenic RNA Pol II transcription sites overlap enhancers. PLoS Biol. 2010;8(5):e1000384.
   PubMed Web of Science ®Google Scholar
• Feyder M, Goff LA, Feyder M, et al. Investigating long noncoding RNAs using animal models Find the latest version: investigating long noncoding RNAs using animal models. J Clin Invest. 2016;126(8):2783–2791.
   Google Scholar
• Luo H, Zhu G, Xu J, et al. HOTTIP lncRNA promotes hematopoietic stem cell self-renewal leading to AML-like disease in mice. Cancer Cell. 2019;36(6):645–659.e8.
   PubMed Web of Science ®Google Scholar
• Luo M, Jeong M, Sun D, et al. Long non-coding RNAs control hematopoietic stem cell function. Cell Stem Cell. 2015;16(4):426–438.
   PubMed Web of Science ®Google Scholar
• Coffre M, Koralov SB. miRNAs in B cell development and lymphomagenesis. Trends Mol Med. 2017;23(8):721–736.
   PubMed Web of Science ®Google Scholar
• Casero D, Sandoval S, Seet CS, et al. Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nat Immunol. 2015;16(12):1282–1291.
   PubMed Web of Science ®Google Scholar
• Brazão TF, Johnson JS, Müller J, et al. Long noncoding RNAs in B-cell development and activation. Blood. 2016;128(7):e10–e19.
   PubMed Web of Science ®Google Scholar
• Petri A, Dybkær K, Bøgsted M, et al. Long noncoding RNA expression during human B-cell development. PLoS One. 2015;10(9):1–19.
   Web of Science ®Google Scholar
• Wilson A, MacDonald HR, Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med. 2001;194(7):1003–1012.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu P, Lin R, et al. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015 March;5:1–10.
   Web of Science ®Google Scholar
• Isoda T, Moore AJ, He Z, et al. Non-coding transcription instructs chromatin folding and compartmentalization to dictate enhancer-promoter communication and T cell fate. Cell. 2017;171(1):103–119.e18.
   PubMed Web of Science ®Google Scholar
• Dolens A, Durinck K, Lavaert M, et al. Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development. EMBO Rep. 2020;21(5):1–20.
   Web of Science ®Google Scholar
• Abarrategui I, Krangel MS. Noncoding transcription controls downstream promoters to regulate T-cell receptor α recombination. Embo J. 2007;26(20):4380–4390.
   PubMed Web of Science ®Google Scholar
• Fu J, Shi H, Wang B, et al. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4+ T cell activation and Sjögren’s syndrome-like autoimmune response. J Autoimmun. 2020 November;107:102358.
   PubMed Web of Science ®Google Scholar
• Johnsson P, Morris KV. Expanding the functional role of long noncoding RNAs. Cell Res. 2014;24(11):1284–1285.
   PubMed Web of Science ®Google Scholar
• Hogan PG. Calcium–NFAT transcriptional signalling in T cell activation and T cell exhaustion. Cell Calcium. 2017;63:66–69.
   PubMed Web of Science ®Google Scholar
• Willingham AT, Orth AP, Batalov S, et al. Molecular biology: a strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science. 2005;309(5740):1570–1573.
   PubMed Web of Science ®Google Scholar
• Sharma S, Findlay GM, Bandukwala HS, et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci U S A. 2011;108(28):11381–11386.
   PubMed Web of Science ®Google Scholar
• Tsao HW, Tai T-S, Tseng W, et al. Ets-1 facilitates nuclear entry of NFAT proteins and their recruitment to the IL-2 promoter. Proc Natl Acad Sci U S A. 2013;110(39):15776–15781.
   PubMed Web of Science ®Google Scholar
• Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol. 2007;7(7):532–542.
   PubMed Web of Science ®Google Scholar
• Huang D, Chen J, Yang L, et al. NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol. 2018;19(10):1112–1125.
   PubMed Web of Science ®Google Scholar
• Vigneau S, Rohrlich P-S, Brahic M, et al. Tmevpg1, a candidate gene for the control of theiler’s virus persistence, could be implicated in the regulation of gamma interferon. J Virol. 2003;77(10):5632–5638.
   PubMed Web of Science ®Google Scholar
• Gomez JA, Wapinski OL, Yang YW, et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell. 2013;152(4):743–754.
   PubMed Web of Science ®Google Scholar
• Petermann F, Pękowska A, Johnson CA, et al. The magnitude of IFN-γ responses is fine-tuned by DNA architecture and the non-coding transcript of Ifng-as1. Mol Cell. 2019;75(6):1229–1242.e5.
   PubMed Web of Science ®Google Scholar
• Hudson WH, Prokhnevska N, Gensheimer J, et al. Expression of novel long noncoding RNAs defines virus-specific effector and memory CD8 + T cells. Nat Commun. 2019;10(1):1–11.
   PubMedGoogle Scholar
• Agresta L, Hoebe KHN, Janssen EM. The emerging role of CD244 signaling in immune cells of the tumor microenvironment. Front Immunol. 2018 NOV;9:1–9.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhong H, Xie X, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112(29):E3883–E3892.
   PubMed Web of Science ®Google Scholar
• Kotzin JJ, Iseka F, Wright J, et al. The long noncoding RNA morrbid regulates CD8 T cells in response to viral infection. Proc Natl Acad Sci U S A. 2019;116(24):11916–11925.
   PubMed Web of Science ®Google Scholar
• Grogan JL, Locksley RM. Thelper cell differentiation: on again, off again. Curr Opin Immunol. 2002;14(3):366–372.
   PubMed Web of Science ®Google Scholar
• Ranzani V, Rossetti G, Panzeri I, et al. The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4. Nat Immunol. 2015;16(3):318–325.
   PubMed Web of Science ®Google Scholar
• Zhang F, Liu G, Wei C, et al. Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF. Faseb J. 2017;31(2):519–525.
   PubMed Web of Science ®Google Scholar
• Collier SP, Collins PL, Williams CL, et al. Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol. 2012;189(5):2084–2088.
   PubMed Web of Science ®Google Scholar
• Collier SP, Henderson MA, Tossberg JT, et al. Regulation of the Th1 genomic locus from ifng through Tmevpg1 by T-bet. J Immunol. 2014;193(8):3959–3965.
   PubMed Web of Science ®Google Scholar
• Zhang H, Nestor CE, Zhao S, et al. Profiling of human CD4+ T-cell subsets identifies the T H2-specific noncoding RNA GATA3-AS1. J Allergy Clin Immunol. 2013;132(4):1005–1008.
   PubMed Web of Science ®Google Scholar
• Gibbons HR, Shaginurova G, Kim LC, et al. Divergent lncRNA GATA3-AS1 regulates GATA3 transcription in T-helper 2 Cells. Front Immunol. 2018 October;9:2512.
   PubMed Web of Science ®Google Scholar
• Spurlock CF, Tossberg JT, Guo Y, et al. Expression and functions of long noncoding RNAs during human T helper cell differentiation. Nat Commun. 2015;6.
   PubMed Web of Science ®Google Scholar
• Tuomela S, Lahesmaa R. Early T helper cell programming of gene expression in human. Semin Immunol. 2013;25(4):282–290.
   PubMed Web of Science ®Google Scholar
• Chien CH, Chiang BL. Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells. J Biomed Sci. 2017;24(1):1–8.
   PubMedGoogle Scholar
• Ying Qiu Y, Wu Y, Jie Lin M, et al. LncRNA-MEG3 functions as a competing endogenous RNA to regulate Treg/Th17 balance in patients with asthma by targeting microRNA-17/RORγt. Biomed Pharmacother. 2018;111:386–394. Nov .
   PubMed Web of Science ®Google Scholar
• Zhou L, Littman DR. Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol. 2009;21(2):146–152.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol. 2007;19(6):409–417.
   PubMed Web of Science ®Google Scholar
• Shui X, Chen S, Lin J, et al. Knockdown of lncRNA NEAT1 inhibits Th17/CD4+ T cell differentiation through reducing the STAT3 protein level. J Cell Physiol. 2019;234(12):22477–22484.
   PubMed Web of Science ®Google Scholar
• Li J, Tian J, Lu J, et al. LncRNA GAS5 inhibits Th17 differentiation and alleviates immune thrombocytopenia via promoting the ubiquitination of STAT3. Int Immunopharmacol. 2019;80:106127. Sept .
   Web of Science ®Google Scholar
• Zhang F, Liu G, Li D, et al. DDIT4 and associated lncDDIT4 modulate Th17 differentiation through the DDIT4/TSC/mTOR pathway. J Immunol. 2018;ji1601689. DOI:10.4049/jimmunol.1601689.
   Web of Science ®Google Scholar
• Brajic A, Franckaert D, Burton O, et al. The long non-coding RNA Flatr anticipates Foxp3 expression in regulatory T cells. Front Immunol. 2018 SEP;9:1–12.
   PubMed Web of Science ®Google Scholar
• Xiong G, Yang L, Chen Y, et al. Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution. Am J Transl Res. 2015;7(11):2262–2269.
   PubMed Web of Science ®Google Scholar
• Xia M, Liu J, Liu S, et al. Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity. Nat Commun. 2017;8(1). DOI:10.1038/ncomms15818.
   Google Scholar
• Tone Y, Furuuchi K, Kojima Y, et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9(2):194–202.
   PubMed Web of Science ®Google Scholar
• Zemmour D, Pratama A, Loughhead SM, et al. Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity. Proc Natl Acad Sci U S A. 2017;114(17):E3472–E3480.
   PubMed Web of Science ®Google Scholar
• Wu Y, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006;126(2):375–387.
   PubMed Web of Science ®Google Scholar
• Jiang R, Tang J, Chen Y, et al. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017 May;8:15129.
   Web of Science ®Google Scholar
• Ondrisova L, Mraz M. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. Front Oncol. 2020 Oct 26;10:591577.
   Google Scholar
• Wang F, Luo L, Gu Z, et al. Integrative analysis of long noncoding RNAs in patients with graft-versus-host disease. Acta Haematol. 2020.
   Web of Science ®Google Scholar
• Pyfrom SC, Quinn CC, Dorando HK, et al. BCALM (AC099524.1) Is a human B lymphocyte-specific long noncoding RNA that modulates B cell receptor–mediated calcium signaling. J Immunol. 2020 Jun;ji2000088.
   Web of Science ®Google Scholar
• Sandoval H, Kodali S, Wang J. Regulation of B cell fate, survival, and function by mitochondria and autophagy. Mitochondrion. 2018 November;41:58–65.
   PubMed Web of Science ®Google Scholar
• Agirre X, Meydan C, Jiang Y, et al. Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response. Nat Commun. 2019;10(1). DOI:10.1038/s41467-019-08679-z.
   PubMedGoogle Scholar
• Syrett CM, Sindhava V, Hodawadekar S, et al. Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells. PLoS Genet. 2017;13(10):1–28.
   Web of Science ®Google Scholar
• Wang J, Syrett CM, Kramer MC, et al. Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X. Proc Natl Acad Sci U S A. 2016;113(14):E2029–E2038.
   PubMed Web of Science ®Google Scholar
• Bunting KL, SoongTD, Singh R, et al. Multi-tiered reorganization of the genome during B cell affinity maturation anchored by a germinal center-specific locus control region. Immunity. 2016;45(3):497–512.
   PubMed Web of Science ®Google Scholar
• Andrews JM, Payton JE. Epigenetic dynamics in normal and malignant B cells: die a hero or live to become a villain. Curr Opin Immunol. 2019;57:15–22.
   PubMed Web of Science ®Google Scholar
• Lu Z, Pannunzio NR, Greisman HA, et al. Convergent BCL6 and lncRNA promoters demarcate the major breakpoint region for BCL6 translocations. Blood. 2015;126(14):1730–1731.
   PubMed Web of Science ®Google Scholar
• Yu K, Lieber MR. Current insights into the mechanism of mammalian immunoglobulin class switch recombination. Crit Rev Biochem Mol Biol. 2019;54(4):333–351.
   PubMed Web of Science ®Google Scholar
• Yewdell WT, Chaudhuri J. A transcriptional serenAID: the role of noncoding RNAs in class switch recombination. Int Immunol. 2017;29(4):183–196.
   PubMed Web of Science ®Google Scholar
• Basu U, Meng F-L, Keim C, et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell. 2011;144(3):353–363.
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. Noncoding RNA transcription targets AID to divergently transcribed loci in B cells. Nature. 2014;514(7522):389–393.
   PubMed Web of Science ®Google Scholar
• Casellas R, Basu U, Yewdell WT, et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat Rev Immunol. 2016;16(3):164–176.
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015;161(4):774–789.
   PubMed Web of Science ®Google Scholar
• Rothschild G, Zhang W, Lim J, et al. Noncoding RNA transcription alters chromosomal topology to promote isotype-specific class switch recombination. Sci Immunol. 2020;5(44):1–14.
   Web of Science ®Google Scholar
• Mraz M, Dolezalova D, Plevova K, et al. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood. 2012;119(9):2110–2113.
   PubMed Web of Science ®Google Scholar
• Mraz M, Stano Kozubik K, Plevova K, et al. The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus. Leuk Res. 2013;37(7):802–808.
   PubMed Web of Science ®Google Scholar
• Mraz M, Pospisilova S. Detection of a deletion at 22q11 locus involving ZNF280A/ZNF280B/PRAME/GGTLC2 in B-cell malignancies: simply a consequence of an immunoglobulin lambda light chain rearrangement. Br J Haematol. 2019;186(4):e91–e94.
   PubMed Web of Science ®Google Scholar
• Wu D, Zhou P, Cao F, et al. Expression profiling and cell type classification analysis in periodontitis reveal dysregulation of multiple lncRNAs in plasma cells. Front Genet. 2020 April;11:1–10.
   PubMed Web of Science ®Google Scholar
• de Lima DS, Cardozo LE, Maracaja-Coutinho V, et al. Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination. Proc Natl Acad Sci U S A. 2019;116(34):17121–17126.
   PubMed Web of Science ®Google Scholar
• Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun. 2010;34(3):168–177.
   PubMed Web of Science ®Google Scholar
• Hrdlickova B, Kumar V, Kanduri K, et al. Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity. Genome Med. 2014;6(10).
   PubMedGoogle Scholar
• Castellanos-Rubio A, Ghosh S. Disease-associated SNPs in inflammation-related lncRNAs. Front Immunol. 2019 MAR;10:1–9.
   PubMed Web of Science ®Google Scholar
• Rankin CR, Shao L, Elliott J, et al. The IBD-associated long noncoding RNA IFNG-AS1 regulates the balance between inflammatory and anti-inflammatory cytokine production after T-cell stimulation. Am J Physiol Gastrointest Liver Physiol. 2020;318(1):G34–G40.
   PubMed Web of Science ®Google Scholar
• Hosseini A, Teimuri S, Ehsani M, et al. LncRNAs associated with multiple sclerosis expressed in the Th1 cell lineage. J Cell Physiol. 2019;234(12):22153–22162.
   PubMed Web of Science ®Google Scholar
• Masoumi F, Ghorbani S, Talebi F, et al. Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018;328:50–59. Jul .
   PubMed Web of Science ®Google Scholar
• Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Prim Care Clin Off Pract. 2018;45(2):237–255.
   PubMed Web of Science ®Google Scholar
• Zhang T-P, Zhu B-Q, Tao S-S, et al. Long non-coding RNAs genes polymorphisms and their expression levels in patients with rheumatoid arthritis. Front Immunol. 2019;10:2529.
   PubMed Web of Science ®Google Scholar
• Wahba AS, Ibrahim ME, Mesbah NM, et al. Long non-coding RNA MEG3 and its genetic variant rs941576 are associated with rheumatoid arthritis pathogenesis in Egyptian patients. Arch Physiol Biochem. 2020 Jul;1–8.
   PubMed Web of Science ®Google Scholar
• Peng H, Ren S, Liu Y, et al. Elevated expression of the long noncoding RNA IFNG-AS1 in the peripheral blood from patients with rheumatoid arthritis. J Immunol Res. 2020;2020:1–8.
   Web of Science ®Google Scholar
• Wang J, Peng H, Tian J, et al. Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome. Immunol Res. 2016;64(2):489–496.
   PubMed Web of Science ®Google Scholar
• Peng H, Liu Y, Tian J, et al. The long noncoding RNA IFNG-AS1 promotes T helper type 1 cells response in patients with hashimoto’s thyroiditis. Sci Rep. 2015 June;5:1–9.
   Web of Science ®Google Scholar
• Luo M, Liu X, Meng H, et al. IFNA-AS1 regulates CD4+ T cell activation in myasthenia gravis though HLA-DRB1. Clin Immunol. 2017;183:121–131.
   PubMed Web of Science ®Google Scholar
• Viatte S, Plant D, Han B, et al. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. J Am Med Assoc. 2015;313(16):1645–1656.
   PubMed Web of Science ®Google Scholar
• Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15(18):2813–2824.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh UG, Agrawal NK, et al. Prevalence of autoantibodies and HLA DR, DQ in type 1 diabetes mellitus. J Clin Diagn Res. 2016;10(7):EC09–EC13.
   PubMed Web of Science ®Google Scholar
• Shi FD, He B, Li H, et al. Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. Eur J Immunol. 1998;28(11):3587–3593.
   PubMed Web of Science ®Google Scholar
• Litinskiy MB, Nardelli B, Hilbert DM, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3(9):822–829.
   PubMed Web of Science ®Google Scholar
• Caro-Maldonado A, Wang R, Nichols AG, et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol. 2014;192(8):3626–3636.
   PubMed Web of Science ®Google Scholar
• Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome. Ann Rheum Dis. 2003;62(2):168–171.
   PubMed Web of Science ®Google Scholar
• Pers JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005;1050(33):34–39.
   PubMedGoogle Scholar
• Dong G, Yang Y, Li X, et al. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus. Biochim Biophys Acta - Mol Basis Dis. 2020;1866(1):165554.
   Web of Science ®Google Scholar
• Karreth FA, Reschke M, Ruocco A, et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 2015;161(2):319–332.
   PubMed Web of Science ®Google Scholar
• De Martino M, De Biase D, Forzati F, et al. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas. Sci Rep. 2020;10(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Omrani MD, Taheri M. Long noncoding RNA PVT1: a highly dysregulated gene in malignancy. J Cell Physiol. 2020;235(2):818–835.
   PubMed Web of Science ®Google Scholar
• Cho SW, Xu J, Sun R, et al. Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element. Cell. 2018;173(6):1398–1412.e22.
   PubMed Web of Science ®Google Scholar
• Tseng YY, Moriarity BS, Gong W, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014;512(1):82–86.
   PubMedGoogle Scholar
• Pear WS, Aster JC, Scott ML, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996;183(5):2283–2291.
   PubMed Web of Science ®Google Scholar
• Durinck K, Wallaert A, Van de Walle I, et al. The notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Haematologica. 2014;99(12):1808–1816.
   PubMed Web of Science ®Google Scholar
• Trimarchi T, Bilal E, Ntziachristos P, et al. Genome-wide mapping and characterization of notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158(3):593–606.
   PubMed Web of Science ®Google Scholar
• Fernando TR, Rodriguez-Malave NI, Waters EV, et al. LncRNA expression discriminates karyotype and predicts survival in B-lymphoblastic leukemia. Mol Cancer Res. 2015;13(5):839–851.
   PubMed Web of Science ®Google Scholar
• Ronchetti D, Manzoni M, Agnelli L, et al. LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome. Blood Cancer J. 2016;6(9):e468.
   PubMedGoogle Scholar
• Tschumper RC, Shanafelt TD, Kay NE, et al. Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia. Oncotarget. 2019;10(1):60–75.
   PubMedGoogle Scholar
• Mraz M, Chen L, Rassenti LZ, et al. MiR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. 2014;124(1):84–94.
   PubMed Web of Science ®Google Scholar
• Cerna K, Oppelt J, Chochola V, et al. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells. Leukemia. 2019;33(2):403–414.
   PubMed Web of Science ®Google Scholar
• Cui B, Chen L, Zhang S, et al. Micro RNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014;124(4):546–554.
   PubMed Web of Science ®Google Scholar
• Garding A, Bhattacharya N, Claus R, et al. Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB. PLoS Genet. 2013;9(4):e1003373.
   PubMed Web of Science ®Google Scholar
• Devan J, Janikova A, Mraz M. New concepts in follicular lymphoma biology: from BCL2 to epigenetic regulators and non-coding RNAs. Semin Oncol. 2018;45(5–6):291–302.
   PubMed Web of Science ®Google Scholar
• Filip D, Mraz M. The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies. Leuk Lymphoma. 2020;61(3):510–524.
   PubMed Web of Science ®Google Scholar
• Shi X, Cui Z, Liu X, et al. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 2019;510(4):594–600.
   PubMed Web of Science ®Google Scholar
• Lu Y, Hu Z, Mangala LS, et al. MYC targeted long noncoding RNA DANCR promotes cancer in part by reducing p21 levels. Cancer Res. 2018;78(1):64–74.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye H, He M, et al. LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma. Biochem Biophys Res Commun. 2018;498(1):207–213.
   PubMed Web of Science ®Google Scholar
• Xiao X, Gu Y, Wang G, et al. c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma. Int J Biol Macromol. 2019 Feb;122:526–537.
   PubMed Web of Science ®Google Scholar
• Hu G, Lou Z, Gupta M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. PLoS One. 2014;9(9).
   Web of Science ®Google Scholar
• Tsutsumi Y, Chinen Y, Sakamoto N, et al. Deletion or methylation of CDKN2A/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality. Leuk Lymphoma. 2013;54(12):2760–2764.
   PubMed Web of Science ®Google Scholar
• Ghesquières H, Larrabee BR, Casasnovas O, et al. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. Br J Haematol. 2018;180(2):286–290.
   PubMed Web of Science ®Google Scholar
• Zhao X, Lwin T, Zhang X, et al. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity. Leukemia. 2013;27(12):2341–2350.
   PubMed Web of Science ®Google Scholar
• Musilova K, Devan J, Cerna K, et al. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. 2018;132(22):2389–2400.
   PubMed Web of Science ®Google Scholar
• Hu G, Gupta SK, Troska TP, et al. Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex. Oncotarget. 2017;8(46):80223–80234.
   PubMedGoogle Scholar
• Wang X, Sehgal L, Jain N, et al. Lncrna malat1 promotes development of mantle cell lymphoma by associating with ezh2. J Transl Med. 2016;14(1):1–14.
   PubMedGoogle Scholar
• Sehgal L, Mathur R, Braun FK, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014;28(12):2376–2387.
   PubMed Web of Science ®Google Scholar
• Blume CJ, Hotz-Wagenblatt A, Hüllein J, et al. P53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia. 2015;29(10):2015–2023.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25(1):267–296.
   PubMed Web of Science ®Google Scholar
• Yan K, Fu Y, Zhu N, et al. Repression of lncRNA NEAT1 enhances the antitumor activity of CD8 + T cells against hepatocellular carcinoma via regulating miR-155/Tim-3. Int J Biochem Cell Biol. 2019 January;110:1–8.
   PubMed Web of Science ®Google Scholar
• Ji J, Yin Y, Ju H, et al. Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC. Cell Death Dis. 2018;9(5).
   Google Scholar
• Mineo M, Lyons SM, Zdioruk M, et al. Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus. Mol Cell. 2020;78(6):1207–1223.e8.
   PubMed Web of Science ®Google Scholar
• Levin AA. Treating disease at the RNA level with oligonucleotides. N Engl J Med. 2019;380(1):57–70.
   PubMed Web of Science ®Google Scholar
• Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia. 2015;29(5):1004–1017.
   PubMed Web of Science ®Google Scholar